Literature DB >> 34222809

Reaction frequency to the skin prick test of inhalant and food allergens in children.

Oner Ozdemir1.   

Abstract

OBJECTIVE: When applied by well-trained personnel, skin prick test (SPT) for a variety of inhalant and/or food allergens is a safe procedure although it may rarely cause systemic reaction. In this article, our aim was to evaluate the reactions after SPTs for the past 6 years in Turkish children having various allergic symptoms brought to our clinic.
METHODS: The results of the SPTs, performed between May 2013 and March 2019, of 12.529 patients whose ages vary from 2 months to 18 years have been retrospectively evaluated.
RESULTS: The average age of the patients who were included in this study was 6.12±4.38 years and 46.4% of them were female. When the patients were categorized according to the diagnosis, it was observed that 4.858 of them with symptoms suggesting asthma; 2.720 of them having symptoms suggesting allergic rhinitis; 1.795 of them having rashes; 906 of them with atopic dermatitis; 352 of them having symptoms suggesting food allergy and the remaining 1.898 with symptoms suggesting various diagnoses. In this study, which reflects our 6-year experience from the results of 12.529 patients, post-SPT reactions have been observed in 9 out of 12.529 patients (0.07%). They were three females and six males. These reactions were observed in 3 eczemas, 2 urticaria, 2 allergic rhinitis, and 2 suggested diagnosis of asthma patients. Their mean age was 5.9±3.5 years. SPT reactions were mostly seen in our five patients having skin disorder (eczema and rashes). The most frequent symptom of vasovagal reaction was syncope, occuring between 1 and 20 min after SPT, in eight of nine patients.
CONCLUSION: During our study, any systemic reaction or anaphylaxis to SPT was not observed. The non-systemic reaction (vasovagal reaction) rate was 7/10.000, similar to the literature. Copyright:
© 2021 by Istanbul Northern Anatolian Association of Public Hospitals.

Entities:  

Keywords:  Anaphylaxis; hypotension; reaction; skin prick test; syncope; vomiting

Year:  2021        PMID: 34222809      PMCID: PMC8240235          DOI: 10.14744/nci.2020.46656

Source DB:  PubMed          Journal:  North Clin Istanb        ISSN: 2536-4553


The skin prick test (SPT) is an in vivo diagnostic test, most commonly used for the evaluation of allergic diseases since it is cheap, very sensitive/specific, and results in a short time. Moreover, it is generally the first choice test in the diagnostic workup for allergic disorders [1-4]. In a recent European Academy of Allergy and Clinical Immunology task force survey, the present practice for allergy diagnosis was found to be depending on SPT as first preference in approximately 2/3 of all allergic disorder types and in 90% of respiratory allergic diseases [5]. It is minimally invasive and has the benefit of testing various allergens up to 20 min. It is done by puncturing the skin, typically in the volar part of the forearm or rarely on the back, with a lancet/an applicator after dropping of an allergen extract. In children, it is far less distressing than venipuncture, used to obtain a blood sample to evaluate specific Immunoglobulin (Ig)E during in vitro tests [1-4]. The current studies have shown that SPT and in vitro specific IgE tests are rather concordant, but with distinct sensitivity and specificity different for each allergen [6, 7]. There is an excellent association (~85–95%) between SPT and in vitro tests. SPT is accepted worldwide, as an outstanding diagnostic tool, with a positive predictive value varying from 95% to100%. SPTs can demonstrate sensitivity to aeroallergens, foods, certain drugs, venom, and latex allergens. In clinical conditions, both tests should be utilized based on clinical characteristics in the history and acquired findings on examinations. Therefore, the significance of such allergen sensitivity should always be cautiously evaluated together with clinical history, since atopic sensitization and real clinical allergy may not concur [1-4]. Concerning reliability, while the reports of systemic reactions and specifically anaphylaxis, in the literature are very uncommon, in vitro serum IgE tests should be chosen if there are prior severe systemic reactions become known from the patient’s clinical history [1]. In fact, when applied by well-trained personnel, SPT for a variety of inhalant and/or food allergens is a safe procedure although it may very rarely cause systemic reaction [8]. Here, our aim was to retrospectively evaluate the reactions after SPTs for the past 6 years in Turkish children having various allergic symptoms.

MATERIALS AND METHODS

Demographic Characteristics

The results of the SPTs, performed between May 2013 and March 2019, of 12.529 patients whose ages vary from 2 months to 18 years have been evaluated retrospectively. This study was approved by the local institutional ethics committee (number: 71522473/050.01.04/32).

Diagnoses of the Patients

When the patients were categorized according to the diagnosis, it was observed that 4.858 of them with symptoms suggesting asthma; 2.720 of them having symptoms suggesting allergic rhinitis; 1.795 of them having rashes; 906 of them with atopic dermatitis; 352 of them having symptoms suggesting food allergy and the remaining 1.898 with symptoms suggesting various diagnoses (Table 1).
TABLE 1

Demographics of our SPT patients

CharacteristicsNumbers
Gender Female/Male5.816/6.713
Average age6.12±4.38 (1–18)
Diagnosis
 Asthma4.858
 Allergic rhinitis2.720
 Urticaria1.795
 Atopic dermatitis906
 Food allergy352
 Others1898

SPT: Skin prick test.

Demographics of our SPT patients SPT: Skin prick test.

Skin Prick Testing

In order to determine the patient’s sensitivity to allergens, multiple SPT method was performed by using an applicator (Expressten®, Medicaperk, Istanbul, Turkey). There were no venom, latex, and drug (antibiotic) allergens used for testing. There was also no prick-to-prick or intradermal testing enrolled in this study. Highlight key points During this study, any systemic reaction or anaphylaxis to SPT was not observed. The most frequent symptom of vasovagal reaction was syncope, happening between 1 and 20 minutes after SPT. The non-systemic reaction (vasovagal reaction) rate was 7/10.000, similar to the literature.

Data Acquisition

Clinical data from enrolled patients in the study were retrospectively acquired from the patients’ files of our outpatient clinic to evaluate the reactions after SPTs for the past 6 years in cases having different allergic symptoms.

Statistical Analysis

Statistical analysis of the study was performed using the Statistical Package for the Social Sciences program (IBM SPSS Statistics, Version 23.0. Armonk, NY, USA). A p<0.05 was considered statistically significant.

RESULTS

The average age of the patients that involved in this study was 6.12±4.38 years and the 46.4% of them were female. In this retrospective study, which reflects our 6-year experience from the results of 12.529 patients, post-SPT reactions have been observed in 9 out of 12.529 patients (0.07%). Out of these nine patients, three were female and six were male patients. These reactions were observed in the three patients with atopic dermatitis, two with urticaria, two with allergic rhinitis, and two with suggested diagnosis of asthma patients. Their mean age was 5.9±3.5 years. The youngest patient was 3.1/2-year-old female and the oldest one was a 13-year-old male. SPT reactions were mostly seen in our five patients having skin disorder (eczema and rashes). The most frequent symptom of vasovagal reaction was syncope, occurring between 1 and 20 min after SPT, in eight out of nine patients. In these four of eight patients, vomiting, tendency to sleep or confirmed hypotension was associated with syncope. Vomiting was associated with syncope in one patient; however, it was the only symptom in one case (#2) as well. Hypotension was accompanying syncope in two cases (#7 and #9). First hypotensive patient was an 11-year-old female and the second one was a 6-year-old male. Moreover, blood pressures of both patients were measured at 80/50 mmHg. Tendency to sleep was seen related with syncope in 1 case. Other vital signs of the patients were stable. Abnormal vital symptoms such as blood pressure of the patient turned to normal values in a short period of time. There was no further intervention needed except for Trendelenburg maneuver. Only one patient, 4-year-old female patient (#3) was monitored for a couple of hours due to parent’s anxiety and tendency to sleep. None of the more serious or systemic allergic reactions e.g. respiratory distress or anaphylaxis was observed in any patient. There was no need for anti-histaminics, corticosteroid, and epinephrine use. None of the patients showed SPT and specific IgE positivity. The routine blood tests, such as complete blood count, CRP, biochemistry were all found to be normal. These symptoms seen in nine patients indicated vasovagal reaction (response) and its related symptoms. (Age, symptoms, and diagnoses of the reactive patients to SPT are presented in Table 2).
TABLE 2

Age, symptoms, and diagnoses of the reactive patients to SPT

Patient#AgeGenderSuggested diagnosisSymptomTested inhalant allergensTested food allergensSPT resultTotal IgESpecific IgE or other testsIntervention
No. 13 y 7 moFemaleAsthmaSyncopeDf, Dog, Chenopodium album, Cladosporium, Meadow Fescue, CupressusHazelnut, fish mixNegative--Trendelenburg

No. 23 y 6 moMaleAtopic dermatitisVomitingDp, cat, alterneria, Chenopodium album, cereal mixCow’s milk, peanut, whole hen’s eggNegative---

No. 34 y 4 moFemaleAllergic rhinitisSyncope, Tendency to sleepDf, Dog, Chenopodium album, Cladosporium, Meadow Fescue, CupressusHazelnut, fish mixNegative17.8 IU/mlFood, tree-grass pollen and mite: negativeTrendelenburg

No. 413 y 1 moMaleUrticariaSyncopeDf, Dog, Chenopodium album, Cladosporium, Pine, Cupressus, English plantain, Cereal mix-Negative<18.2Cow’s milk, egg, nuts, fruits: negativeTrendelenburg

No. 510 y 3 moMaleUrticariaSyncopeDp, cat, alterneria, Meadow Fescue, olive, ash, nettle, Mugwort-Negative-Inhalant and food allergen screening: negativeTrendelenburg

No. 64yMaleAtopic dermatitisSyncopeDf, Dog, Chenopodium album, Cladosporium, Meadow Fescue, CupressusHazelnut, fish mixNegative--Trendelenburg

No. 711 y 1 moFemaleAtopic dermatitisSyncope HypotensionDp, cat, alterneria, Meadow Fescue, olive, ash, nettle, Mugwort-Negative-Spirometry: normalTrendelenburg

No. 85 y 6 moMaleChronic cough, asthma?Syncope, vomitingDf, Dog, Chenopodium album, Cladosporium, Cupressus, Meadow FescueHazelnut, fish mixNegative--Trendelenburg

No. 95 y 10 moMaleAllergic rhinitisSyncope, HypotensionDp, cat, alterneria, Meadow Fescue, olive, ash, nettle, Mugwort-Negative-Spirometry: Mildly low FEV1, FVCTrendelenburg

Dp: Dermatophagoides pteronyssinus; Df: Dermatophagoides farina; FEV1: Forced expiratory volume in 1 second; FVC: Forced vital capacity. SPT: Skin prick test; y: Year; mo: Month.

Age, symptoms, and diagnoses of the reactive patients to SPT Dp: Dermatophagoides pteronyssinus; Df: Dermatophagoides farina; FEV1: Forced expiratory volume in 1 second; FVC: Forced vital capacity. SPT: Skin prick test; y: Year; mo: Month.

DISCUSSION

There have been earlier reports on fatal reactions, later systemic (non-fatal) reactions and reaction rate to SPT in the literature from various countries [9-13]. This is the first Turkish study surveying reactions to SPT from the center in Sakarya Province. In 1987, Lockey et al. [9] reported nine fatal reactions between 1895 and 1968 and six fatal reactions from 1964 through 1983. One of the six fatalities was tested with simultaneously SPT and intradermally; five were due to only intradermal testing. Bernstein et al. [10] described 12-year (1990–2001) survey of one deadly event after SPT. One fatal anaphylactic reaction was confirmed in a young woman with allergic rhinitis, moderate persistent but uncontrolled asthma and food allergy after application of SPT to 90 food antigens using a SPT device. Reid et al. [11] observed one skin test-related fatality in a follow-up of fatal events that occurred in their survey between 1985 and 1989. Norrman et al. [12] determined the systemic reaction rate after the SPT as 0.001% in a prospective study enrolling 5908 children. They defined vasovagal reaction rate as 0.12% . Sellaturay et al. [13] demonstrated systemic reaction rate as %0.077 in a 6-year long prospective study including 31,000 patients. The most likely causative allergens were food allergens. The relevant SPT wheal was ≥8 mm in 75% of them. In a study including 16,505 SPT patients from 1992 to 1997, Valyasevi et al. [14] detected systemic reaction rate as 0.03% for SPT. In their retrospective review querying the practice’s electronic billing database by Swender et al. [15], there were 28,907 total patient encounters for SPT. This study showed a systemic reaction rate requiring epinephrine of 20/100,000 SPT visits. Our literature overview showed that fatal and/or severe systemic reactions reported in the past literature seemed to mostly happen after intradermal injections, skin testing during allergy season, and/or skin testing done in uncontrolled asthma or sick patients. Reactions were also associated with skin testing to multiple food allergens and drug [8-17]. Although no systemic reaction or anaphylaxis has not observed in our study and rarely reported in the literature, all of the emergency equipment/medication including epinephrine must be ready to use during skin testing. The patients ought to be examined before a SPT and necessary precautions should be taken, especially for patients having uncontrolled asthma, polysensitization, and high degree of SPT reactivity with a specific consideration to such foods as all types of nuts, fish, etc [9].

Conclusion

In this study, there was no systemic reaction or anaphylaxis to SPT was not observed. The non-systemic vasovagal reaction rate was 7 out of 10.000 (9/12.529) cases, in concordance with the literature.
  17 in total

1.  Systemic reactions to allergy skin tests.

Authors:  M A Valyasevi; D E Maddox; J T Li
Journal:  Ann Allergy Asthma Immunol       Date:  1999-08       Impact factor: 6.347

Review 2.  Skin testing in allergy.

Authors:  Gayatri Patel; Carol Saltoun
Journal:  Allergy Asthma Proc       Date:  2019-11-01       Impact factor: 2.587

3.  Diagnostic Capacity of Commercial Extracts vs Prick-by-Prick in the Study of Sensitization to Peanut: Which Technique Should We Use?

Authors:  C M D'Amelio; A García-Moral; J Bartra; J Azofra; E García Blanca; M D Quiñones; M J Goikoetxea; R Martínez-Aranguren; G Gastaminza
Journal:  J Investig Allergol Clin Immunol       Date:  2020-05-06       Impact factor: 4.333

4.  IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper.

Authors:  Ignacio J Ansotegui; Giovanni Melioli; Giorgio Walter Canonica; Luis Caraballo; Elisa Villa; Motohiro Ebisawa; Giovanni Passalacqua; Eleonora Savi; Didier Ebo; R Maximiliano Gómez; Olga Luengo Sánchez; John J Oppenheimer; Erika Jensen-Jarolim; David A Fischer; Tari Haahtela; Martti Antila; Jean J Bousquet; Victoria Cardona; Wen Chin Chiang; Pascal M Demoly; Lawrence M DuBuske; Marta Ferrer Puga; Roy Gerth van Wijk; Sandra Nora González Díaz; Alexei Gonzalez-Estrada; Edgardo Jares; Ayse Füsun Kalpaklioğlu; Luciana Kase Tanno; Marek L Kowalski; Dennis K Ledford; Olga Patricia Monge Ortega; Mário Morais Almeida; Oliver Pfaar; Lars K Poulsen; Ruby Pawankar; Harald E Renz; Antonino G Romano; Nelson A Rosário Filho; Lanny Rosenwasser; Mario A Sánchez Borges; Enrico Scala; Gian-Enrico Senna; Juan Carlos Sisul; Mimi L K Tang; Bernard Yu-Hor Thong; Rudolf Valenta; Robert A Wood; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2020-02-25       Impact factor: 4.084

5.  In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan-An EAACI position paper.

Authors:  Ludger Klimek; Hans J Hoffmann; Ayse F Kalpaklioglu; Pascal Demoly; Ioana Agache; Todor A Popov; Antonella Muraro; Peter Schmid-Grendelmeier; Sergio Bonini; Andreas Bonertz; Vera Mahler; Stefan Vieths; Oliver Pfaar; Torsten Zuberbier; Marek Jutel; Carsten Schmidt-Weber; Peter W Hellings; Sten Dreborg; Matteo Bonini; Helen A Brough; Jean Bousquet; Karin Hoffmann-Sommergruber; Oscar Palomares; Markus Ollert; Mohamed H Shamji; Victoria Cardona
Journal:  Allergy       Date:  2020-09       Impact factor: 13.146

Review 6.  The skin prick test.

Authors:  F Frati; C Incorvaia; C Cavaliere; G Di Cara; F Marcucci; S Esposito; S Masieri
Journal:  J Biol Regul Homeost Agents       Date:  2018 Jan-Feb       Impact factor: 1.711

7.  Survey of fatalities from skin testing and immunotherapy 1985-1989.

Authors:  M J Reid; R F Lockey; P C Turkeltaub; T A Platts-Mills
Journal:  J Allergy Clin Immunol       Date:  1993-07       Impact factor: 10.793

8.  Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001.

Authors:  David I Bernstein; Mark Wanner; Larry Borish; Gary M Liss
Journal:  J Allergy Clin Immunol       Date:  2004-06       Impact factor: 10.793

9.  Adverse reactions to skin prick testing in children - prevalence and possible risk factors.

Authors:  Gunilla Norrman; Karin Fälth-Magnusson
Journal:  Pediatr Allergy Immunol       Date:  2009-02-10       Impact factor: 6.377

10.  Allergen-specific IgE: comparison between skin prick test and serum assay in real life.

Authors:  D Bignardi; P Comite; I Mori; F Ferrero; V Fontana; M Bruzzone; M Mussap; G Ciprandi
Journal:  Allergol Select       Date:  2019-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.